Literature DB >> 29190150

Intravenous saline administration in patients with severe acquired brain injury and orthostatic intolerance for tilt-table mobilization.

Christian Riberholt1, Niels Olesen2,3, Peter Hovind4, Jesper Mehlsen5, Tue Hvass Petersen1.   

Abstract

PRIMARY
OBJECTIVE: This study aimed to investigate the effect of intravenous saline administration on orthostatic hypotension (OH) during head up tilt (HUT) and the change in the renin-angiotensin-aldosterone system before and after HUT in patients with severe acquired brain injury (ABI). RESEARCH
DESIGN: The study is designed as an observational study. METHODS AND PROCEDURES: Fourteen patients with ABI, low level of consciousness and OH were monitored before, during and after HUT with non-invasive beat-to-beat blood pressure measurement, and transcranial Doppler determination of middle cerebral artery blood flow velocity. Blood samples were collected before and after two HUT sessions separated by 1 hour and saline was administered in between. MAIN OUTCOMES AND
RESULTS: Patients' ability to stand upright did not change after saline administration due to OH. The patients showed signs of reduced cerebral autoregulation at both HUT sessions. The patients had a significant lower level of renin and angiotensin II but not aldosterone.
CONCLUSIONS: Patients with severe ABI and OH demonstrate no improvement in standing time with reduced plasma renin and angiotensin II after two HUT sessions and 1 hour fluid administration. Research focusing on the ability to retain fluid after bed rest is warranted.

Entities:  

Keywords:  Cerebral autoregulation; head up tilt; rehabilitation; renin–angiotensin–aldosterone system

Mesh:

Substances:

Year:  2017        PMID: 29190150     DOI: 10.1080/02699052.2017.1408144

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  1 in total

1.  Early Orthostatic Exercise by Head-Up Tilt With Stepping vs. Standard Care After Severe Traumatic Brain Injury Is Feasible.

Authors:  Christian Gunge Riberholt; Markus Harboe Olsen; Christian Baastrup Søndergaard; Christian Gluud; Christian Ovesen; Janus Christian Jakobsen; Jesper Mehlsen; Kirsten Møller
Journal:  Front Neurol       Date:  2021-04-14       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.